Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene and miRNA expression in radioiodine refractory and avid papillary thyroid carcinomas (miRNA expresseion dataset)

ABSTRACT: Gene and miRNA expression in radioiodine refractory and avid papillary thyroid carcinomas (miRNA expresseion dataset)

PROVIDER: PRJNA635079 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Gene and miRNA expression in radioiodine refractory and avid papillary thyroid carcinomas

Project description:Gene and miRNA expression in radioiodine refractory and avid papillary thyroid carcinomas

| PRJNA635074 | ENA

Gene and miRNA expression in radioiodine refractory and avid papillary thyroid carcinomas (gene expression dataset)

Project description:Gene and miRNA expression in radioiodine refractory and avid papillary thyroid carcinomas (gene expression dataset)

| PRJNA635080 | ENA

Gene and miRNA expression in radioiodine refractory and avid papillary thyroid carcinomas (miRNA expresseion dataset)

Project description:We performed gene and miRNA expression profiling in a series of 39 papillary thyroid carcinomas (PTCs) and 13 matched non-neoplastic thyroids derived from PTC patients with metastatic disease and submitted to radioiodine (RAI) treatment.

2021-05-17 | GSE151180 | GEO

Gene and miRNA expression in radioiodine refractory and avid papillary thyroid carcinomas (gene expression dataset)

2020-11-24 | GSE151179 | GEO

Normal thyrocytes vs papillary vs anaplastic thyroid carcinomas

Project description:We profiled the gene expression of 11 anaplastic thyroid carcinomas (ATC), 49 papillary thyroid carcinomas (PTC) and 45 normal thyroids (N)

2012-11-09 | GSE33630 | GEO

Transcription profiling of sporadic and radiation-induced papillary carcinomas

Project description:transcriptome comparison of radiation-induced papillary thyroid carcinomas with sporadic papillary thyroid carcinomas

2005-10-27 | E-MEXP-485 | biostudies-arrayexpress

Normal thyrocytes vs papillary vs anaplastic thyroid carcinomas

Project description:We profiled the gene expression of 11 anaplastic thyroid carcinomas (ATC), 49 papillary thyroid carcinomas (PTC) and 45 normal thyroids (N) We hibridized a series of anaplastic thyroid carcinomas (ATC) and papillary thyroid carcinomas (PTC) onto Affymetrix U133 Plus 2.0 arrays. ATCs were obtained from different hospitals in France and Belgium. Paired RNA samples of PTCs and non-tumoral thyroid tissues were obtained from Ukraine via the Chernobyl Tissue Bank (www.chernobyltissuebank.com). Diagnoses were confirmed by the members of the International Pathology Panel of the Chernobyl Tissue Bank.

2012-11-09 | E-GEOD-33630 | biostudies-arrayexpress

Gene Expression Analysis of Papillary Thyroid Carcinoma with Lymph Node Metastasis and Radioactive Iodine Refractive

Project description:Radioiodine therapy (RAI) is a safe and effective treatment for DTC. It significantly increases the life expectancy of DTC patients. However, 60% of patients with recurrent or distant metastatic PTC will be radioiodine refractory (RAI-R), where 131I uptake does not occur. Patients with RAI-R thyroid cancer have a poor outcome, with a 5-year disease-specific survival rate of 60% to 70%. Therefore, resensitization of RAI-R tumours to RAI has the potential to improve survival for DTC patients. Therefore, we used the Agilent One-Colour SurePrint G3 Human Gene Expression V3 Microarray on primary thyroid tumours of 5 PTC patients with negative LN and RAI-avid, 5 PTC patients with positive LN and non-RAI-avid and 4 adjacent normal thyroid tissues to identify potential genes involved in iodine uptake. The extracted microarray data was analysed using AltAnalyze and NetworkAnalyst software to determine differentially expressed probesets. We used p-value < 0.05 and log2 fold change ≥1 or ≤-1 as the criteria for chosen significantly differentially probesets. Then, we used ShinyGo to annotate the probesets, determine gene type, and distribution analysis. We also used FunRich to make VennDiagram.

2025-08-06 | GSE299988 | GEO

Proteomic analysis of radioiodine-refractory differentiated thyroid cancer

Project description:Radioiodine refractory differentiated thyroid cancer (RR-DTC) is the main factor affecting the overall survival rate of thyroid cancer clinically. In order to investigate its underlying molecular mechanism of pathogenesis with the hope to explore novel therapeutic targets for clinical treatment, we performed a comparative proteomic analysis in tumor tissue of patients with RR-DTC and papillary thyroid cancer.

2022-11-05 | PXD037968 |

Deregulated Expression of the 14q32 miRNA Cluster in Clear Cell Renal Cell Carcinomas

Project description:Clear cell renal cell carcinomas (ccRCC) are characterized by arm-wide chromosomal alterations. Loss at 14q is associated with disease aggressiveness in ccRCC, which responds poorly to chemotherapeutics. The 14q locus contains one of the largest miRNA clusters in the human genome; however, little is known about the contribution of these miRNAs to ccRCC pathogenesis. In this regard, we investigated the expression pattern of selected miRNAs at the 14q32 locus in TCGA kidney tumors and in ccRCC cell lines. We validated that the miRNA cluster is downregulated in ccRCC (and cell lines) as well as in papillary kidney tumors relative to normal kidney tissues and primary renal proximal tubule epithelial (RPTEC) cells. We demonstrated that agents modulating expression of DNMT1 (e.g., 5-Aza-deoxycytidine) could modulate miRNA expression in ccRCC cell lines. Lysophosphatidic acid (LPA, a Lysophospholipid mediator elevated in ccRCC) not only increased labile iron content but also modulated expression of 14q32 miRNAs. Through an overexpression approach targeting a subset of 14q32 miRNAs (specifically at subcluster A: miR-431, miR-432, miR-127, and miR-433) in 769-P cells, we uncovered changes in cellular viability and claudin-1, a tight junction marker. A global proteomic approach was implemented using these miRNA overexpressing cell lines which uncovered ATXN2 as a highly downregulated target, which has a role in chronic kidney disease pathogenesis. Collectively, these findings support a contribution of miRNAs at 14q32 in ccRCC pathogenesis.

2023-05-10 | PXD036428 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data